Screener
Outlook Therapeutics, Inc. OTLK Q1 2026 earnings
Reported May 15, 2026 · Before market open
Revenue$128.0KMiss by $4.3M
EPS-$0.16Miss by $0.04
Revenue estimate$4.4M
EPS estimate-$0.12
Next report
Date not yet announcedVersus estimates
Revenue
Q2 2026$9.0KMiss by $957.7K
Q1 2026$128.0KMiss by $4.3M
Q4 2025-$1.2MMiss by $4.4MQ3 2025-$91.8KMiss by $5.9MQ2 2025$1.5MMiss by $4.3MDiluted EPS
FAQ
- When did Outlook Therapeutics, Inc. report Q1 2026 earnings?
- Outlook Therapeutics, Inc. (OTLK) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Outlook Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Outlook Therapeutics, Inc. reported revenue of $128.0K and eps of $-0.16 for Q1 2026.
- Did Outlook Therapeutics, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $4.4M by $4.3M. EPS missed the consensus estimate of $-0.12 by $0.04.
- How did Outlook Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 60.0% from $-0.40.
- Where can I find Outlook Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-060305) and the 10-Q periodic report (0001104659-26-062632) directly on SEC EDGAR. The filing index links above go to sec.gov.
